The $59B Invested by Venture Capital Firms in 2014

A total of $59 billion has been invested in 5,272 deals globally in 2014 so far, compared to $37bn invested in 5,940 deals over the same period in 2013, following to Preqin‘s latest analysis of global venture capital investment activity.

While activity for the third quarter is below that of Q2 2014, the amount of capital invested is 45% higher than during the same quarter in 2013.

“Entrepreneurial companies worldwide have received a welcoming boost in 2014, with almost $60bn invested in young companies throughout the first three quarters of the year – 60% up on the amount invested during the same period last year. Asia in particular has seen a notable surge in activity, with investment levels across India and Greater China increasing significantly over the course of the year. The two largest venture capital deals of the quarter also took place in India and China. While the pace of new investments has slowed in 2014 compared to 2013, all stages of investment, with the exception of growth capital/expansion, have larger average deal sizes in 2014 so far than in 2013.”

Source: ValueWalk

 

Tags: Venture Capital, Venture Capital Firm, Venture Capital Group, Venture Capital Industry, Venture Capital Investment, Venture Capital Investor, Venture Capital Fund, VC Funding, VC, Preqin, India, Greater China, China.


Tile Inc. Raises $13M in Seed and Series A Funding

GGV Capital, a venture capital firm focused on expansion stage investments in the US and Asia, has led a series A round for Tile Inc., an application and hardware device designed for the iOS platform.

Tile Inc. has raised $13 million in seed and Series A funding to sell technology that helps people find things that have been lost, left behind or stolen.

The company aims to create what it calls “the world’s largest lost and found.”

The San Mateo, Calif., company makes and sells $20 “Tiles,” which are 1.5-square-inch waterproof tags that employ Bluetooth low-energy radio and GPS technology. Users affix the tags to their belongings, and if they lose an item–such as keys, a purse, remote control or some more prized possession–they can search for it with Tile’s mobile iOS app.

The Tile app detects whether a tagged item is within a 100-foot range, and makes the tag beep so that users can follow the noise to their misplaced item. If the object is outside of this short range, the Tile system can detect the last place where it was located, and give the user the approximate location so they can retrieve it.

Source: Wall Street Journal

 

Tags: Venture Capital, Venture Capital Firm, Venture Capital Group, Venture Capital Industry, Venture Capital Investment, Venture Capital Investor, Venture Capital Fund, VC Funding, VC, GGV Capital, US, Asia, Tile Inc., Application, Hardware, iOS, San Mateo, California, Bluetooth, GPS Technology, iOS App.


Bitcoin Wallet Startup Coinapult Scores $775K

Barry Silbert’s Bitcoin Opportunity Corp, angel investor Roger Ver and technology-focused VC firm FirstMark Capital, invested the amount of $750,000 in Coinapult, a Bitcoin wallet startup based in Panama.

The Panama-based bitcoin wallet service provider raised the capital through two rounds of funding, and aims to use the money for additional marketing and product improvements.

Speaking to CoinDesk, Coinapult CFO and COO Justin Blincoe indicated that the biggest benefit for his company will be the expertise of its now-solidified investor group, which he characterized as essential to his company’s success in an increasingly crowded bitcoin wallet market.

Lawrence Lenihan, founder and managing director at FirstMark Capital, a VC firm whose past investments include Lumosity, Pinterest and Shopify, was optimistic about Coinapult and its long-term prospects in light of these challenges.

Source: CoinDesk

 

Tags: Venture Capital, Venture Capital Firm, Venture Capital Group, Venture Capital Industry, Venture Capital Investment, Venture Capital Investor, Venture Capital Fund, VC Funding, VC, Barry Silbert, Bitcoin Opportunity Corp, Angel Investor, Roger Ver, FirstMark Capital, Coinapult, Bitcoin Wallet Startup, Panama, CoinDesk, Coinapult, Justin Blincoe, Lawrence Lenihan, Lumosity, Pinterest, Shopify, Coinapult.


365Scores Raises $5.5M from Investors

Mobile sports application company 365Scores has raised $5.5 million in a financing round from LETA Capital, Cedar Fund, Titanium Investments and other private investors.

Offering apps for iOS and Android — the latter of which has just hit the 5 million download mark — 365Scores competes with major brands such as ESPN Sports Center, Yahoo Sports, and CBS Sports, in addition to a number of startups playing in the same space, such as Fanatix, to name but one.

The app lets users follow their favorite teams, athletes, and sports on mobile and get live push notifications — 2 billion have been sent so far in aggregate — to keep them up-to-date with the important moments in a game, and serves news, scores, and photo and video updates. It also pulls in news and updates from local sports news outlets and social media.

As you’d expect, there’s a (recently introduced) social aspect of its own, too, dubbed a “Virtual Stadium,” it enables fans around the world to converse. The idea is to encourage users to socialise via the app during and after a game or other sporting event, and to talk smack over team line-ups, the play in action and, of course, the result. Bolstering those social features is one of the things 365Scores says it will invest in with today’s new funding round.

Source: TechCrunch

 

Tags: Venture Capital, Venture Capital Firm, Venture Capital Group, Venture Capital Industry, Venture Capital Investment, Venture Capital Investor, Venture Capital Fund, VC Funding, VC, Mobile Sports Application, 365Scores, LETA Capital, Cedar Fund, Titanium Investments, iOS, Android, ESPN Sports Center, Yahoo Sports, CBS Sports, Fanatix, Virtual Stadium.


Johnson & Johnson Buys Alios for $1.75B

Johnson & Johnson, a venture-backed biotechnology company, has agreed to pay the amount of $1.75 billion in cash to acquire antiviral drug-maker Alios BioPharma in the largest acquisition record.

Alios is developing a promising orally administered treatment for respiratory syncytial virus, known as RSV. It is currently in Phase 2 studies.

“We are excited that this acquisition will enable us to explore treatment options for a number of viral infections, including RSV, the last of the major pediatric diseases with no available preventive therapy,” said William N. Hait, the head of research and development at Janssen Pharmaceutical Companies, a division of Johnson & Johnson. The compound Alios is developing “complements our existing early stage portfolio for RSV which aims to prevent and treat this disease, the leading cause of acute lower respiratory infection in children under the age of five.”

Source: The New York Times

 

Tags: Venture Capital, Venture Capital Firm, Venture Capital Group, Venture Capital Industry, Venture Capital Investment, Venture Capital Investor, Venture Capital Fund, VC Funding, VC, Johnson & Johnson, J&J, Biotechnology Company, Antiviral Drug-Maker, Alios BioPharma, RSV, William N. Hait, Janssen Pharmaceutical Companies.


Netuitive Banks $6.5M to Grow Its New Predictive IT Analytics Platform

MK Capital, a $250 million venture capital fund with headquarters in Chicago, has led a $6.5 million in equity financing for Netuitive, a provider of IT analytics.

The Reston company automates performance monitoring for an organization’s applications and infrastructure, both in the cloud and on the premise. Netuitive said the cash will go toward an upcoming release that will “allow unprecedented scaling” of its analytics software. It will also expand the cloud deployment of its behavior learning engine, which helps its customers to predict IT problems before they emerge.

MK Capital and Rembrandt Venture Partners led the equity round. Also participating are Columbia Capital, based in Alexandria, and Cross Creek Advisors, according to a news release. Under the deal, Rembrandt General Partner Doug Schrier will join Netuitive’s board.

The latest financing bring’s Netuitive’s total venture haul to $29.5 million, according to Crunchbase.

Source: Washington Business Journal‎

 

Tags: Venture Capital, Venture Capital Firm, Venture Capital Group, Venture Capital Industry, Venture Capital Investment, Venture Capital Investor, Venture Capital Fund, VC Funding, VC, MK Capital, Chicago, Chicago Venture Capital, Netuitive, IT Analytics Provider, Rembrandt Venture Partners, Columbia Capital, Alexandria, Cross Creek Advisors, Doug Schrier.


CyberAgent Ventures Invests in Indonesia’s News App Development

The Japanese venture capital CyberAgent Ventures has invested into a startup Merah Putih, which is developing a news app in Indonesia called Kurio for Android and iOS-based smartphones.

Kurio is the fifth Indonesian company to receive investment from CyberAgent. The firm previously invested in ecommerce companies Tokopedia, Bilna, and VIP Plaza, as well as game developer Touchten.

Since the application launched in late 2013, Kurio claims it has received over 50,000 downloads. The app understands what news to deliver to users based on their preferences, but also recognizes and delivers topics related to their careers. Users can select topics from the start menu and browse articles they find interesting.

Kurio founder David Wayne Ika told DailySocial, “I personally really wanted an investment from Cyber Agent and it was the only VC I approached since we made our prototype [...] I respect that they can see our long-term vision.”

Source: Tech in Asia

 

Tags: Venture Capital, Venture Capital Firm, Venture Capital Group, Venture Capital Industry, Venture Capital Investment, Venture Capital Investor, Venture Capital Fund, VC Funding, VC, Japan, Japan Venture Capital, CyberAgent Ventures, Merah Putih, News App, Kurio, Android, iOS, Ecommerce Company, Tokopedia, Bilna, VIP Plaza, Touchten, David Wayne Ika, DailySocial, Cyber Agent.


Meet CoLucid’s CEO Thomas P. Mathers

The article below is an overview about Thomas P. Mathers, the CEO of CoLucid Pharmaceuticals, Inc., a biotechnology company, focuses on therapies for central nervous system disorders.

Tom joined CoLucid as Chief Executive Officer in 2011. He has more than twenty two years of executive management experience in the life sciences and medical device industry. Mr. Mathers also serves as the chairman and co-founder of Déclion Pharmaceuticals, as a director of CureFAKtor Pharmaceuticals, as serves on the Board of Directors for the Biotechnology Industry Organization (BIO) where he is active in the policy areas of capital formation, bioethics, intellectual property and regulatory policy.

Prior to CoLucid, Tom served as president and CEO of Peptimmune, Inc.; president and CEO of Cell Based Delivery; vice president and general manager of Cardion AG; vice president of Strategic Development at Genzyme; and management positions at Snowden-Pencer and Pfizer, Inc.

Source: TVM Capital Life Science Venture Capital

 

Tags: Venture Capital, Venture Capital Firm, Venture Capital Group, Venture Capital Industry, Venture Capital Investment, Venture Capital Investor, Venture Capital Fund, VC Funding, VC, Thomas P. Mathers, CoLucid Pharmaceuticals, Inc., Biotechnology Company, Déclion Pharmaceuticals, CureFAKtor Pharmaceuticals, Biotechnology Industry Organization, BIO, Peptimmune, Inc., Cell Based Delivery, Cardion AG, Genzyme, Snowden-Pencer, Pfizer, Inc.


Indonesia’s VC Firm JD Capital Raises $200 for its Fund II

JD Capital, Indonesia-based venture capital firm, has raises the amount of $200 million for its latest fund entitled Jiuding China Growth Fund II.

The vehicle, otherwise known as the Two US Dollars Fund will be used to invest in in the consumer, services, medicine, agriculture and equipment industries as we as well as state-owned restructuring projects.

LPs committing to the fund included sovereign wealth funds, insurance companies and other institutional investors based in North American and Asia, said JD in a regulatory filing posted on stock market information website Hexun.com.

JDC aims to develop ethical business leaders by creating what it refers to as an “edupreneur environment” where people are trained about business by working.

Source: AltAssets

 

Tags: Venture Capital, Venture Capital Firm, Venture Capital Group, Venture Capital Industry, Venture Capital Investment, Venture Capital Investor, Venture Capital Fund, VC Funding, VC, Indonesia, Indonesia Venture Capital, JD Capital, Jiuding China Growth Fund II, Two US Dollars Fund, Consumer, Services, Medicine, Agriculture, Equipment Industries, Sovereign Wealth Funds, Insurance Companies, Institutional Investors, North America, Asia.


Pure Advertising Joins T-Bird Pharma for IR Services

A pharmaceutical company focused on developing premium quality medical marijuana products T-Bird Pharma Inc. has appointed Pure Advertising & Marketing Inc. to provide investor relations services on behalf of the company.

Pure is an established venture capital advisory firm based in Vancouver, BC and has successfully demonstrated the ability to work with junior companies in articulating a company’s inherent value to the investment community and strategic partners. The Agreement is for a term of eighteen months and may be terminated by either party by giving 90 days’ written notice of such termination. The Company will pay a monthly retainer fee to Pure of $7,500 plus HST and any reasonable pre-approved expenses incurred on behalf of the Company. The Company has also granted Kam Thindal, the sole shareholder of Pure, 300,000 incentive options to purchase shares of the Company. The options will follow the guidelines set out in the Company’s stock option plan and as set forth by TSX Venture Exchange policy. The investor relations agreement, options and option pricing are subject to the approval of the TSX Venture Exchange.About PurePure is owned by Mr. Kam Thindal. The firm works with junior public and private emerging companies to provide capital markets advisory and capital raising services in a variety of industries and sectors.

Source: MarketWatch

 

Tags: Venture Capital, Venture Capital Firm, Venture Capital Group, Venture Capital Industry, Venture Capital Investment, Venture Capital Investor, Venture Capital Fund, VC Funding, VC, Pharmaceutical Company, T-Bird Pharma Inc., Pure Advertising, Pure Advertising & Marketing Inc., Vancouver, BC, Canada, Kam Thindal, TSX Venture Exchange, Mr. Kam Thindal.


Former Epizyme President Joins Atlas Venture as Partner

Jason Rhodes, former President and Chief Financial Officer of Epizyme, has been appointed by Atlas Venture, an early stage venture capital firm investing in promising life sciences and technology innovation, as a partner effective October 1, 2014.

At Atlas, Rhodes will work closely with the life sciences team to build groundbreaking companies. He brings an accomplished record in company creation, deal making and venture investing.

“This is an important and exciting time in the life sciences, with profound scientific discoveries being translated into meaningful clinical advances that will shape the way patients are treated for decades to come,” said Rhodes. “Atlas has a unique and successful strategy for creating and realizing value for patients and investors that is made possible by strong relationships with leading scientists, entrepreneurs and the venture community. I am thrilled to be joining the Atlas team.”

Source: citybizlist

 

Tags: Venture Capital, Venture Capital Firm, Venture Capital Group, Venture Capital Industry, Venture Capital Investment, Venture Capital Investor, Venture Capital Fund, VC Funding, VC, Jason Rhodes, Epizyme, Atlas Venture.


Reddit Scores $50M in New Venture Capital Funding

Reddit, the popular online message board, announced that it has raised the amount of $50 million in new venture capital funding.

The website known as the “front page of the Internet” is getting a cash infusion from a long list of investors that includes Y Combinator president Sam Altman, Marc Andreessen of Andreessen Horowitz and the rapper Snoop Dogg.

Reddit is well-known for its primitive website design and laissez-faire attitude toward moderating its users. The company is a former subsidiary of Conde Nast that was later spun off into an independent company. CEO Yishan Wong said the new funding will help Reddit grow its relatively small staff of 60 and improve its app and ad products. “An investment like this doesn’t mean we’re rich or successful,” Wong said in a blog post. “Money can become worthless very quickly, value is something that is built over time through hard work.”

Source: TIME

 

Tags: Venture Capital, Venture Capital Firm, Venture Capital Group, Venture Capital Industry, Venture Capital Investment, Venture Capital Investor, Venture Capital Fund, VC Funding, VC, Reddit, Online Message Board, Y Combinator, Sam Altman, Marc Andreessen, Andreessen Horowitz, Snoop Dogg, Conde Nast, Yishan Wong.


Allakos Adds $10M to Its Series A Round

Allakos Inc. announced it has secured an additional $10 million investment from current investors including Novo Ventures, Alta Partners, RiverVest Venture Partners and the Roche Venture Fund.

Allakos said in a statement on its website Tuesday that the funding will help the company continue developing its flagship program, an antibody that affects types of cells related to inflammation. Also, Allakos announced that it hired Alejandro Dorenbaum, as its new chief medical officer.

The biotechnology company was founded in 2012 by CEO Christopher Bebbington and Nenad Tomasevic, vice president of research. The company’s current investors include Novo Ventures, Alta Partners, RiverVest Venture Partners and the Roche Venture Fund, all of whom participated in the Series A round.

Allakos said its technology will have potential in “multiple, high-value markets, including large established indications as well as orphan diseases,” said Bebbington. “The additional funding will enable us to advance two programs towards meaningful near-term milestones.”

Source: Silicon Valley Business Journal‎

 

Tags: Venture Capital, Venture Capital Firm, Venture Capital Group, Venture Capital Industry, Venture Capital Investment, Venture Capital Investor, Venture Capital Fund, VC Funding, VC, Allakos Inc., Novo Ventures, Alta Partners, RiverVest Venture Partners, Roche Venture Fund, Alejandro Dorenbaum, Christopher Bebbington, Nenad Tomasevic.


Hercules Backs ChromaDex Corp. with $5M

Hercules Technology Growth Capital, Inc., the leading specialty finance company focused on providing senior secured loans, has invested the amount of $5 million into ChromaDex Corp., an innovative natural products company that provides proprietary ingredients and science-based solutions.

The financing will provide ChromaDex with additional working capital to support its rapidly-growing ingredient business, as well as accelerate the Company’s research and development efforts.

Commenting on the announcement, Frank Jaksch, CEO and Founder of ChromaDex, stated: “This financing should provide ChromaDex with sufficient capital to fund our operations at least until late 2015, as our business transitions to cash flow positive and profitable. The Hercules funding will provide ample working capital to continue to grow the emerging ingredient segment of our business, allow us to accelerate the R&D efforts on our existing ingredient portfolio, and continue to develop our new ingredient pipeline. We are pleased to partner with Hercules, a NYSE listed specialty finance company with over $1.0 billion in total assets.”

Source: MarketWatch

 

Tags: Venture Capital, Venture Capital Firm, Venture Capital Group, Venture Capital Industry, Venture Capital Investment, Venture Capital Investor, Venture Capital Fund, VC Funding, VC, Hercules Technology Growth Capital, Inc., ChromaDex Corp., Frank Jaksch, NYSE.


Industry Ventures Closes $170M VC Fund of Funds

A San Francisco-based investment firm for venture capital Industry Ventures LLC, announced it has closed its third venture capital fund of funds at $170 million.

The fund, which was oversubscribed, is called Industry Ventures Partnership Holdings III, L.P.

The Fund will target primary commitments and early secondary purchases in smaller venture capital funds as well as direct investments alongside its managers. This latest close brings the firm’s total capital under management to over $2 billion. It had most recently closed a $425 million secondary fund in December of last year.

Founded in 2000, Industry Ventures invests with two kinds of strategies. First, it does secondary funds that offer liquidity alternatives for direct investments and limited partnership interests. It also does funds of funds that invest in small funds with outsized return potential; this is what Industry Ventures Partnership Holdings III will do.

“Partnership Holdings focuses on investing with small venture funds, typically sub-$250 million, through LP interests, meaning primary commitments and early secondary purchases, and direct co- investments,” Roland Reynolds, Managing Director at Industry Ventures, explained to me.

Source: VatorNews

 

Tags: Venture Capital, Venture Capital Firm, Venture Capital Group, Venture Capital Industry, Venture Capital Investment, Venture Capital Investor, Venture Capital Fund, VC Funding, VC, San Francisco, San Francisco Venture Capital Firm, Industry Ventures LLC, Ventures Partnership Holdings III, L.P., Roland Reynolds.


S3 Ventures Leads $5.4M Round for Pristine

S3 Ventures, an earlier stage venture firm with $185 million under management, has led a $5.4 million funding round for Pristine, a startup developing healthcare apps for Google Glass.

Austin-based S3 Ventures led the round, which also included Capital Factory, HealthFundr and several clients. The company plans to use the money to expand its research and development, sales, marketing and operations teams.

“The team at S3 has pioneered cutting-edge developments in medical devices, enterprise health IT solutions, and more,” Kyle Samani, cofounder and CEO of Pristine, said in a news release. “With our rapid growth, we are thrilled to have partners with a strong track record of guiding early stage companies to success.”

Pristine’s first product, EyeSight is a video platform for Google Glass that complies with government healthcare regulations for privacy. The company has since branched out with the application into the pharmaceutical, medical device and manufacturing industries with applications for support and training.

Source: Silicon Hills News

 

Tags: Venture Capital, Venture Capital Firm, Venture Capital Group, Venture Capital Industry, Venture Capital Investment, Venture Capital Investor, Venture Capital Fund, VC Funding, VC, Austin, Austin Venture Capital, S3 Ventures, Pristine, Healthcare Apps Startup, Startup, Google Glass, Capital Factory, HealthFundr, Kyle Samani, Video Platform, EyeSight.


New York City Startup Parcel Scores $1M in Seed Funding Round

Parcel Inc., a New York City-based startup, is planning to grow a delivery service that helps city dwellers get the packages they bought online without the hassles of having to pick them up at a mail center or lug them home from work after the raise of $1 million in funding round.

Founder and Chief Executive Jesse Kaplan said Parcel users attain a unique ID from his startup, and when they shop online, they have their orders sent to Parcel’s facilities instead of to their own city addresses.

This proves especially useful if they don’t have the luxury of doormen to sign for their packages or can’t sit around at home waiting for their new iPhones or shoes from Zappos, he said.

Parcel then delivers the packages after hours, when customers are home, within a one-hour window.

For now, Parcel operates in Manhattan only, with a new “beta” service starting in Brooklyn on Monday. The company only handles items that are less than two feet in any dimension and weigh 30 pounds or less.

Source: Wall Street Journal

 

Tags: Venture Capital, Venture Capital Firm, Venture Capital Group, Venture Capital Industry, Venture Capital Investment, Venture Capital Investor, Venture Capital Fund, VC Funding, VC, Parcel Inc., New York City, New York City Startup, Startup, Jesse Kaplan, Zappos, Manhattan, Brooklyn.


San Diego Entrepreneurs Form 412 New Startup in 2013

Despite a drop in venture capital funding for the San Diego’s young firms, local entrepreneurs created 412 new startup companies and 1,200 jobs in 2013.

City and business leaders highlighted these numbers on Monday from the semiannual Connect Innovation Report as evidence that San Diego remains a hub for startups.

“There is a lot happening in San Diego that we tend to lose track of,” said Greg McKee, chief executive of Connect, a nonprofit focused on helping entrepreneurs. “We are always getting beaten up a little bit vis-à-vis Boston and San Francisco. But when you look at the information, there is a lot of activity here.”

Of the 412 startups that opened their doors last year, 233 were software firms. “We are beginning to see an absolute boom in software across the region,” said Mayor Kevin Faulconer at a news conference.

Source: U-T San Diego

 

Tags: Venture Capital, Venture Capital Firm, Venture Capital Group, Venture Capital Industry, Venture Capital Investment, Venture Capital Investor, Venture Capital Fund, VC Funding, VC, San Diego Young Firm, San Diego Entrepreneurs, Connect Innovation Report, Greg McKee, Connect, Boston, Kevin Faulconer.


Interviewing a Venture Capitalist Dana Rosenberg

The article below is an interview about Dana Rosenberg, an MBA student at Wharton with a passion for startups and venture capital.

Dana is currently working with Maveron, a consumer-only venture firm based in Seattle and San Francisco. Prior to Wharton, Dana was active in digital health startups, first leading user acquisition and engagement at consumer health startup, HealthTap, and more recently, leading strategic partnership at startup accelerator, Rock Health. In her spare time, Dana is a member of the investment team on Dorm Room Fund and volunteers for Women 2.0 to promote female founders in technology.

So, tell us a bit about yourself and how you found yourself in VC investing?

I’ve always had an interest in technology startups and a deep respect for entrepreneurs who were bold enough to pursue their own ideas. While working for a healthcare startup in Palo Alto, I started volunteering for an organization called Women 2.0, which supports female founders in technology. My work with them helped me realized that I am more interested in enabling other founders than in being in an operational role myself.

Source: Wharton Journal

 

Tags: Venture Capital, Venture Capital Firm, Venture Capital Group, Venture Capital Industry, Venture Capital Investment, Venture Capital Investor, Venture Capital Fund, VC Funding, VC, Dana Rosenberg, MBA Student, Startup, Maveron, Seattle, San Francisco, Consumer Health Startup, HealthTap, Startup Accelerator, Rock Health, Dorm Room Fund, Palo Alto.


LAVCA Strengths Its Board of Directors with Two New Hires

Carlos Garcia, Victoria Capital Partners’ co-managing Partner and chairman, and Alfredo Castellanos Heuer, Evercore Mexico Capital Partners’ senior managing director, joined the board of the Latin American Private Equity & Venture Capital Association.

Garcia and Castellanos succeed J. Scott Swensen, Co-Founder of Conduit Capital Partners, and Arturo Saval, Managing Director of Nexxus Capital, who completed six-year terms on the LAVCA board.

“Scott and Arturo have made major contributions to LAVCA during a period of substantial growth in Latin America private equity and venture capital,” said Patrice Etlin, Chairman of LAVCA. “Incorporating new board members allows us to further expand the association’s networks and expertise. Carlos brings decades of regional PE experience, while Alfredo represents one of the most important PE investors active in Mexico today.”

Source: LAVCA

 

Tags: Venture Capital, Venture Capital Firm, Venture Capital Group, Venture Capital Industry, Venture Capital Investment, Venture Capital Investor, Venture Capital Fund, VC Funding, VC, Private Equity, Private Equity Firm, Private Equity Group, Private Equity Company, Carlos Garcia, Victoria Capital Partners, Alfredo Castellanos Heuer, Evercore Mexico Capital Partners, Latin American Private Equity & Venture Capital Association, LAVCA, J. Scott Swensen, Conduit Capital Partners, Arturo Saval, Nexxus Capital, Patrice Etlin.


Accel Leads a $26M Series B Round for Qubit

Accel Partners, a venture and growth equity firm, has led a $26 million in series B funding round for big-data ecommerce analytics startup Qubit.

Salesforce Ventures also participated in the round, along with existing investor Balderton Capital. The startup raised a Series A round of $7.5 million in 2012, and has raised $36.5 million in total since being founded back in 2010 by a group of ex-Googlers.

Qubit said it plans to use the new funding for continued R&D investment, including predictive data, and for pushing aggressively in the U.S.

“We have some very exciting developments in predictive data and empowering marketers to take control of their optimization strategies,” said co-founder and CEO Graham Cooke. “We’re also continuing to scale up our sales, professional services and marketing teams in the U.S. and Europe.”

Source: TechCrunch

 

Tags: Venture Capital, Venture Capital Firm, Venture Capital Group, Venture Capital Industry, Venture Capital Investment, Venture Capital Investor, Venture Capital Fund, VC Funding, VC, Accel Partners, Big-Data Ecommerce, Startup, Qubit, Salesforce Ventures, Balderton Capital, Graham Cooke, US, Europe.


Boston Venture Capital Fund Plans to Strength Local Startups

A Boston-based venture capital fund Atlas Venture is planning to stoke the laggard New England technology startup scene.

The firm recently formalized a group called Boston Syndicates, known as BOSS, after starting it earlier this year. BOSS is made up of 23 New England-based entrepreneurs and investors, who can band together to raise money for local technology companies. Once they invest in a Boston-area startup, Atlas will put an additional $250,000 into the company.

“We wanted to give easier access to capital to the tech industry in the Boston-area, which has been lagging behind Silicon Valley,” Jeff Fagnan, a partner at Atlas, said in an interview.

Atlas is pushing the program after New England, which had a plethora of technology startups more than a decade ago, has fallen behind other regions in entrepreneurship. The San Francisco Bay area is the top hub for technology investments and startups formation, while New York City surpassed Boston to take the second spot in 2010, said Anand Sanwal, chief executive officer of CB Insights, a New York-based venture capital research firm.

Source: Bloomberg

 

Tags: Venture Capital, Venture Capital Firm, Venture Capital Group, Venture Capital Industry, Venture Capital Investment, Venture Capital Investor, Venture Capital Fund, VC Funding, VC, Boston, Boston Venture Capital, Atlas Venture, New England Technology Startup, Technology Startup, Boston Startup, Startup, Boston Syndicates, BOSS, Silicon Valley Jeff Fagnan, San Francisco, New York City, Anand Sanwal, CB Insights, New York, New York Venture Capital.


Venture Capital Trust Fund Grows Initiatives to Fund Agriculture in Ghana

Venture Capital Trust Fund is establishing a Soya Value Chain Project in Ghana with the objective of financing of seed germination and production of soya beans for the poultry industry.

The initiative of the Venture Capital Trust Fund (VCTF) targets nucleus farmers, out-growers and farmer-based organizations to benefit from the project.

The value chain intervention strategies seek to build partnerships with key institutions, especially incubators and centres of innovation, to promote entrepreneurship with the aim of covering research findings into potential business proposals and viable businesses for funding.

“It is expected that this collaboration and the associated research thereof will go towards improving productivity and economic outputs from the Soya industry,” said the Trust Fund’s Chief Executive Officer, Daniel Duku.

Since its inception in 2006, the Trust Fund has disbursed $3.5million in agricultural value chain financing of cereals and grains for the poultry, livestock and brewery industries.

Source: GhanaWeb

 

Tags: Venture Capital, Venture Capital Firm, Venture Capital Group, Venture Capital Industry, Venture Capital Investment, Venture Capital Investor, Venture Capital Fund, VC Funding, VC, Venture Capital Trust Fund, Soya Value Chain Project, Ghana, Daniel Duku.


Ukraine’s First Trade Association

Private equity and venture capital firms are hoping to draw attention to the industry in Ukraine with the launch of the country’s first trade association for firms in the PE and VC sector.

The Ukrainian Venture Capital and Private Equity Association was formed last week with the aim of shaping “the future direction of the private equity industry by promoting investment opportunities in Ukraine, representing interests of private equity investors to policymakers and improving [the] investment and business climate in Ukraine.”

Founder Jaanika Merilo said that the group has 32 members of which 18 are private equity and venture capital firms and the remainder are firms or institutions associated with private equity. “The message is: Keep investing in Ukraine. It’s the best way to change perception,” said Ms. Merilo.

Members include AVentures, Ukrainian Partners and the Warsaw Stock Exchange.

The conflict in Ukraine has prompted some private equity firms to look at their exposure to Russia. The Blackstone Group scrapped plans to hire Moscow-based Dmitri Kushaev as a senior adviser, while Kurt Bjorklund, co-managing partner of London-based firm Permira, quit the board of the Russian Direct Investment Fund in August.

Source: Wall Street Journal

 

Tags: Venture Capital, Venture Capital Firm, Venture Capital Group, Venture Capital Industry, Venture Capital Investment, Venture Capital Investor, Venture Capital Fund, VC Funding, VC, Private Equity, Private Equity Firm, Private Equity Group, Private Equity Company, Private Equity Fund, Private Equity Investment, Ukraine Private Equity, Ukraine Venture Capital, Ukrainian Venture Capital and Private Equity Association, Jaanika Merilo, AVentures, Ukrainian Partners, Warsaw Stock Exchange, Russia, Blackstone Group, Moscow, Dmitri Kushaev, Kurt Bjorklund, London, Permira, Russian Direct Investment Fund.


Argus Cyber Security Scores $4M in Series A Venture Funding

The automotive cyber security company Argus Cyber Security reported that it has raised the amount of $4 million in Series A funding in a round led by Magma Venture Partners and Vertex Venture Capital.

The round included Magma Venture Partners and Vertex Venture Capital, two leading venture capital funds, and a group of prominent investors including Zohar Zisapel, founder of the RAD Group.

As cars become connected to the Internet and to external devices such as smartphones, smart keys, diagnostic tools and other vehicles, the more vulnerable they are to cyber-attacks. These malicious intrusions may compromise a vehicle’s Electronic Control Units (ECUs), allowing manipulation of a car’s engine, brakes, airbags and other safety systems or vehicle components.

Argus provides the automotive industry a unique Intrusion Prevention System (IPS), based on patent-pending Deep Packet Inspection (DPI) algorithms. It prevents a vehicle’s critical components from being hacked in real-time and can be seamlessly integrated into any vehicle production line. The Argus IPS also generates reports and alerts for remote monitoring of a vehicle’s cyber health.

Source: AftermarketNews

 

Tags: Venture Capital, Venture Capital Firm, Venture Capital Group, Venture Capital Industry, Venture Capital Investment, Venture Capital Investor, Venture Capital Fund, VC Funding, VC, Automotive Cyber Security Company, Argus Cyber Security, Magma Venture Partners, Vertex Venture Capital, Zohar Zisapel, RAD Group, Electronic Control Units, ECUs, Intrusion Prevention System, IPS, Deep Packet Inspection, DPI.


Tallwood Venture Capital Pours into Ikanos Communications

Ikanos Communications, Inc., a broadband communications semiconductor and software supplier, announced it has raised $16.25 million in new round of funding from Tallwood Venture Capital and Alcatel-Lucent.

They will purchase respectively USD 11.25 million and USD 5.0 million in Ikanos shares at a price of USD 0.41 per share. Alcatel-Lucent also agreed to loan the company up to USD 10.0 million and will work with Ikanos on the development of ultra-broadband products. In addition, Tallwood agreed to purchase an additional USD 11.25 million of stock at the same per share price.

In order to offer the company’s other stockholders the same ability as Tallwood to purchase shares, Ikanos will register a rights offering of 144.9 million shares. Tallwood has indicated its intention to purchase, between its initial purchase of USD 11.25 million in the private placement, and the rights offering, an aggregate of USD 22.5 million of stock. Subject to the over-allotment option available to all stockholders, including Tallwood, and to Alcatel-Lucent’s purchase of USD 5.0 million of common stock in the private placement, any stockholder purchasing its pro rata share in the base offering will not be diluted by virtue of Tallwood’s share purchase.

Source: Telecompaper‎

 

Tags: Venture Capital, Venture Capital Firm, Venture Capital Group, Venture Capital Industry, Venture Capital Investment, Venture Capital Investor, Venture Capital Fund, VC Funding, VC, Ikanos Communications, Inc., Broadband Communications Semiconductor, Software Supplier, Tallwood Venture Capital, Alcatel-Lucent.


Adaptimmune Raises $104M to Develop New Cancer Treatments

A biotechnology company Adaptimmune Ltd. which has offices in Oxford, England, and Philadelphia, has raised the amount of $104 million in its series A venture capital round of funding to develop new cancer treatments.

The series A venture capital financing round was led by New Enterprise Associates of Menlo Park, Calif. Other investors included the University of Oxford, OrbiMed Advisors, Wellington Management Co., Fidelity Biosciences, Foresite Capital Management, Ridgeback Capital Management, Novo A/S, QVT, Rock Springs Capital, venBio Select and Merlin Nexus.

Adaptimmune plans to use the proceeds from the stock sale to advance the development of its experimental products for multiple cancer indications. The company’s initial targets are multiple myeloma, melanoma, sarcoma and ovarian cancer.

Founded in 2008, Adaptimmune is developing T-cell therapy to treat cancer and infectious disease. The approach involves strengthening the ability of the body’s own immune defense-system machinery (T-cells) to target and destroy cancerous or infected cells.

Adaptimmune opened a U.S. office in the University City Science Center in 2011. In June, the company entered into a collaboration and licensing agreement, valued at up to $450 million, with GlaxoSmithKline.

Source: Philadelphia Business Journal

 

Tags: Venture Capital, Venture Capital Firm, Venture Capital Group, Venture Capital Industry, Venture Capital Investment, Venture Capital Investor, Venture Capital Fund, VC Funding, VC, Biotechnology Company, Adaptimmune Ltd., Oxford, England, Philadelphia, Cancer Treatments, New Enterprise Associates, Menlo Park, California, University of Oxford, OrbiMed Advisors, Wellington Management Co., Fidelity Biosciences, Foresite Capital Management, Ridgeback Capital Management, Novo A/S, QVT, Rock Springs Capital, venBio Select, Merlin Nexus, T-Cell Therapy, US Office, University City Science Center.


Agrisoma Biosciences Secures $8M in Series A Round

Cycle Capital Management, a private equity and venture capital firm specializing in start-ups, early, mid, and late venture stages, has led an $8 million series A funding round for a Canadian agricultural technology company Agrisoma Biosciences Inc.

Cycle Capital Management led the round and was joined by existing investor BDC Venture Capital, Gatineau, Quebec-based Agrisoma said in a statement Sept. 26.

The company’s Resonance Carinata plant is in commercial production in the U.S. and Canada and the funding will help Agrisoma expand to “multiple locations globally,” according to the statement. Carinata, a non-food oilseed, is one of four crops certified as sustainable by the Roundtable on Sustainable Biomaterials.

Source: Bloomberg

 

Tags: Venture Capital, Venture Capital Firm, Venture Capital Group, Venture Capital Industry, Venture Capital Investment, Venture Capital Investor, Venture Capital Fund, VC Funding, VC, Cycle Capital Management, Private Equity, Private Equity Firm, Private Equity Group, Private Equity Company, Startup, Canada, Canadian Agricultural Technology Company, Agrisoma Biosciences Inc., BDC Venture Capital, Gatineau, Quebec, Resonance Carinata, US.


Comprimato Secures €1M from Venture Capital Backers

Former backers Credo Ventures and Y Soft Venture Capital invested the amount of €1 million in Comprimato, a Brno, Czech Republic-based provider of JPEG2000 GPU-based compression solutions.

The company intends to use the funds to expand both sales as well as the technology.

Founded by Jiri Matela, CEO, as a spin off from Prague-based research institute CESNET, Comprimato provides its compression solution to the digital cinema market and secured numerous clients including Digimetrics or Stanford University. It is also in negotiation with major global players in various fields including military and health applications.

Source: FinSMEs

 

Tags: Venture Capital, Venture Capital Firm, Venture Capital Group, Venture Capital Industry, Venture Capital Investment, Venture Capital Investor, Venture Capital Fund, VC Funding, VC, Credo Ventures, Y Soft Venture Capital, Comprimato, Brno, Czech Republic, JPEG2000 GPU, Jiri Matela, Prague, CESNET, Digimetrics, Stanford University.


Magma Venture Partners Completes Fundraising for Its Fund IV

An Israeli venture capital firm with $500 million under management Magma Venture Partners, is pleased to announce that has raised the amount of $500 million for its newest fund entitled Magma Venture Capital IV with $150 million in new committed capital.

The fund, which was oversubscribed within weeks of its announcement, comes on the heels of a third fund raised in early 2012, Magma said.

The new fund will continue Magma’s focus of investing in information, communication technology including mobile, cloud, new media, software as a service, e-commerce and cyber security.

The fund will invest with Israeli entrepreneurs in earlier stages of development. It is expected to begin investing in early 2015 in 25 to 30 companies with typical investments of $500,000 to $6 million.

Magma’s past investments include Waze, which was acquired by Google, and Onavo, which was bought by Facebook.

Source: Reuters

 

Tags: Venture Capital, Venture Capital Firm, Venture Capital Group, Venture Capital Industry, Venture Capital Investment, Venture Capital Investor, Venture Capital Fund, VC Funding, VC, Israel, Israeli Venture Capital, Magma Venture Partners, Magma Venture Capital IV, Waze, Google, Onavo, Facebook.


Page 6 of 91« First...567...Last »

Wilson Holding Company



Platinum Members Log-in

Log-in to your Platinum Membership.